1. Home
  2. TSN vs TEVA Comparison

TSN vs TEVA Comparison

Compare TSN & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyson Foods Inc.

TSN

Tyson Foods Inc.

HOLD

Current Price

$56.86

Market Cap

19.7B

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$28.43

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSN
TEVA
Founded
1935
1901
Country
United States
Israel
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7B
30.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TSN
TEVA
Price
$56.86
$28.43
Analyst Decision
Hold
Strong Buy
Analyst Count
10
8
Target Price
$61.70
$27.00
AVG Volume (30 Days)
3.7M
11.4M
Earning Date
11-10-2025
11-05-2025
Dividend Yield
3.58%
N/A
EPS Growth
N/A
N/A
EPS
1.33
0.62
Revenue
$54,441,000,000.00
$16,776,000,000.00
Revenue This Year
$4.28
$4.74
Revenue Next Year
$0.76
$0.48
P/E Ratio
$42.87
$46.12
Revenue Growth
2.12
0.02
52 Week Low
$50.56
$12.47
52 Week High
$64.36
$28.68

Technical Indicators

Market Signals
Indicator
TSN
TEVA
Relative Strength Index (RSI) 59.59 80.93
Support Level $52.65 $24.01
Resistance Level $58.67 $26.96
Average True Range (ATR) 1.27 0.68
MACD 0.14 0.19
Stochastic Oscillator 69.93 94.65

Price Performance

Historical Comparison
TSN
TEVA

About TSN Tyson Foods Inc.

Tyson Foods is a protein-focused food producer, selling raw chicken, beef, pork, and prepared foods. Chicken and beef are its two largest segments, each composing about one third of US sales. Prepared foods constituted 18% of fiscal 2024 sales and include brands like Tyson, Jimmy Dean, Hillshire Farm, Ball Park, and Sara Lee. However, most of these are in product categories rife with competition where Tyson does not have a massive market share lead. Tyson sells some products overseas, but the international segment accounts for just 4% of total revenue. The company is an active acquirer, with more recent years' purchases focused on international and food-service markets.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: